Loading clinical trials...

A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00490451

A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma

The primary purpose of the study is to estimate the time from the first dose of LY573636-sodium (hereafter referred to as LY573636) to the date your physician determines that your disease has progress...

Lead sponsor: Eli Lilly and Company•10 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITING

Colorectal Resections in Patients With Retroperitoneal Sarcoma

NCT06943612 · Sarcoma, Soft Tissue, Retroperitoneal Sarcoma

COMPLETEDNA

Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas

NCT02415816 · Sarcoma, Bone, Sarcoma, Soft Tissue, and more

COMPLETEDPhase 1

Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

NCT05858710 · Sarcoma, Soft Tissue

Not Yet RecruitingNA

Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors

NCT06550765 · Sarcoma, Soft Tissue, Sarcoma, Spindle Cell

COMPLETEDPhase 2

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

NCT02584309 · Sarcoma, Soft Tissue, Soft Tissue Sarcoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 18, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment101

Start dateAug 2007

Last updatedSep 18, 2019

Condition

Sarcoma, Soft Tissue

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Miami, Florida

Tampa, Florida

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 18, 2019Data synced to Clareo: May 16, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions